Additionally, more research is needed to explore potential modifiers, such as maternal age, coexisting maternal conditions, and gestational age at thrombophilia diagnosis, to provide a more comprehensive understanding of the impact of aPL-associated thrombophilia on pregnancy outcomes. The gene discussed is FASLG; the disease is thrombophilia.